Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
These are all the trades in excess of 20,000 shares for Friday, a mixture, but one sell of 1.25m after hours.
GDRG.L
Display: Time and Sales, Filters: Trading Day, # of Days: , Days Back: 1
Volume Range: >= 20000
Timestamp Venue TICK Last Trade Volume
2021-02-05 17:07:29.381 XOFF UP 98.5 149,794
2021-02-05 16:50:31.221 AIMX DOWN 86.68 1,250,000
2021-02-05 16:31:01.000 AIMX DOWN 95 249,999
2021-02-05 16:11:23.349 AIMX DOWN 99.157 27,017
2021-02-05 15:58:20.808 AIMX UP 98.165 20,000
2021-02-05 15:36:39.055 AIMX UP 98 20,000
2021-02-05 15:10:33.131 AIMX DOWN 96.2728 25,000
2021-02-05 14:58:51.837 AIMX DOWN 97.7 22,210
2021-02-05 14:56:12.715 AIMX UP 97.975 22,914
2021-02-05 14:55:17.093 AIMX UP 97.1 25,000
2021-02-05 14:54:03.184 AIMX DOWN 97.975 20,404
2021-02-05 14:16:48.000 AIMX UP 97 25,000
2021-02-05 14:15:55.928 AIMX UP 97 20,611
2021-02-05 14:03:35.371 AIMX UP 97.9 20,421
2021-02-05 12:43:24.992 AIMX UP 98 40,000
2021-02-05 12:42:23.847 AIMX UP 98 24,542
2021-02-05 12:29:56.006 AIMX UP 99.6917 40,113
2021-02-05 12:18:41.751 AIMX DOWN 98.375 20,000
2021-02-05 12:02:11.274 AIMX UP 99 25,000
2021-02-05 12:01:54.374 AIMX DOWN 98.6 25,000
2021-02-05 12:00:59.325 AIMX DOWN 98.0455 25,000
2021-02-05 11:59:59.451 AIMX DOWN 98 25,000
2021-02-05 11:39:40.870 AIMX UP 96.667 300,000
2021-02-05 11:30:18.116 AIMX UP 98.6 26,604
2021-02-05 11:19:29.683 AIMX DOWN 97.7216 20,000
2021-02-05 11:19:06.656 AIMX DOWN 98.2 22,486
2021-02-05 11:02:18.048 AIMX UP 98.9 50,549
2021-02-05 10:42:51.039 AIMX DOWN 95.9866 70,301
2021-02-05 10:17:36.041 AIMX DOWN 99.625 20,081
2021-02-05 10:16:40.166 AIMX DOWN 99.625 20,086
2021-02-05 09:58:41.241 AIMX UP 101.5 35,000
2021-02-05 09:55:54.092 AIMX DOWN 99.4 49,428
2021-02-05 09:52:27.819 AIMX UP 99.9 30,000
2021-02-05 09:45:55.464 AIMX UP 97.9999 25,000
2021-02-05 09:44:46.993 AIMX UP 97.9999 25,504
2021-02-05 09:44:17.000 AIMX UP 97.98 25,509
2021-02-05 09:12:52.000 AIMX DOWN 92 190,000
2021-02-05 09:05:01.335 AIMX UP 94.899 20,000
2021-02-05 08:35:18.416 AIMX UP 94.75 25,000
2021-02-05 08:35:08.117 AIMX UP 94.7 22,696
2021-02-05 08:32:15.622 AIMX UP 94.5 25,912
2021-02-05 08:31:46.085 AIMX UP 94.5 50,000
BB
2021-02-05 16:35:06.089 AIMX DOWN 98.5 6,403 99 100
2021-02-05 16:29:48.902 AIMX UP 100 400 99 100
2021-02-05 16:29:46.641 AIMX DOWN 99.5 1,275 99 100
2021-02-05 16:29:38.676 AIMX UP 100 325 99 100
2021-02-05 16:29:35.394 AIMX DOWN 99.5 2,000 99 100
2021-02-05 16:29:27.285 XOFF UP 100 10 100 100
2021-02-05 16:29:27.285 XOFF UP 100 2 100 100
2021-02-05 16:29:27.285 XOFF UP 100 5 100 100
2021-02-05 16:29:00.882 AIMX DOWN 99.31 5,260 99 100
2021-02-05 16:28:55.454 AIMX UP 100 2,500 99 100
2021-02-05 16:28:53.605 AIMX UP 100 349 99 100
2021-02-05 16:28:38.608 AIMX UP 99.99 94 99 100
Sadiq, I got in about the same time as you, however after averaging down I'm now in profit for the first time since May. Last week, even though i'd averaged down I was over 60% down on my holding but bought more GDR after following this bullitin board. I hope you get back into profit too soon. :)
Just to confuse matters more Rodney, Kromek KMK are the ones who received the funding whish was announced on Wednesday. Ther's no mention of any Genedrive collaberation so Proactive Investor seems to have their story mixed up?
https://www.proactiveinvestors.com/companies/news/28427/clifton-star-resources-unveils-excellent-gold-recovery-in-biox-albion-tests--28427.html
Epistem Holdings signs up to help police with DNA identification
Biotech firm Epistem Holdings (LON:EHP) is collaborating with the National Policing Improvement Agency to help develop a human DNA identification system.
The two organisations will evaluate Epistem’s Genedrive molecular device as part of the NPIA’s ADAPT (Accelerated DNA Profiling Technology) programme.
The NPIA was set up to provide critical national services to support frontline policing. It is aimed at helping the police to save money and operate efficiently.
The organisation plans to use Genedrive to target the ‘amelogenin’ sex gene and other single tandem repeats (STRs) that create the human DNA fingerprint. If trials are successful, the NPIA could use Genedrive to enable rapid and accurate DNA analysis at a crime scene, leading to improved speed of identification and reduced cost.
Epistem says its Genedrive technology provides a “breakthrough in molecular diagnostic testing” by providing a rapid, low cost, simple-to-use device with high sensitivity and specificity. Developed as a handheld device, it brings a “point of need” approach to disease diagnosis and identification across a broad spectrum of DNA-related areas from human identification for policing purposes to pharmacogenomic use in oncology, virology, ophthalmology and the detection of infectious diseases.
The ADAPT evaluation programme in the NPIA is planned to continue into next year, and if successful it will be rolled out into a number of police forces in the UK.
From The Telegraph
RSI: 38 No clear indication according to RSI.
Stochastic: 30 No clear indication according to Stochastic.
MACD: MACD is above the MACD signal which might indicate a positive momentum in stock
ADX: 27 This could indicate that stock has a strong negative trend.
SMA 20 & 50: The last 20 day's moving average (48.52) is below the last 50 day's moving average (74.85). This is theoretically a negative sign.
SMA 100 & 200: The last 100 day's moving average (96.22) is above the last 200 day's moving average (75.37). This is theoretically a positive sign.